
They are gearing up for something big in Novo Nordisk’s haemophilia division. But to the general public the disease haemophilia is not normally what you would associate the Danish pharmaceutical giant with.
A database search of Danish newspaper articles reveals that there were 1,006 articles containing the words ‘diabetes’ and ‘Novo Nordisk’ published in the last five years, while the word ‘haemophilia’ only appeared in conjunction with the company’s name in 54 instances.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app